FDA Drug information
RETACRIT
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- RETACRIT EPOETIN 10000 [iU]/mL Pfizer Laboratories Div Pfizer Inc
- RETACRIT EPOETIN 10000 [iU]/mL Pfizer Laboratories Div Pfizer Inc
- RETACRIT EPOETIN 10000 [iU]/mL Vifor (International) Inc.
- RETACRIT EPOETIN 10000 [iU]/mL Vifor (International) Inc.
- RETACRIT EPOETIN 2000 [iU]/mL Pfizer Laboratories Div Pfizer Inc
- RETACRIT EPOETIN 2000 [iU]/mL Vifor (International) Inc.
- RETACRIT EPOETIN 20000 [iU]/mL Pfizer Laboratories Div Pfizer Inc
- RETACRIT EPOETIN 20000 [iU]/mL Vifor (International) Inc.
- RETACRIT EPOETIN 3000 [iU]/mL Pfizer Laboratories Div Pfizer Inc
- RETACRIT EPOETIN 3000 [iU]/mL Vifor (International) Inc.
- RETACRIT EPOETIN 4000 [iU]/mL Pfizer Laboratories Div Pfizer Inc
- RETACRIT EPOETIN 4000 [iU]/mL Vifor (International) Inc.
- RETACRIT EPOETIN 40000 [iU]/mL Pfizer Laboratories Div Pfizer Inc
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.